Biopharma Credit Investments V (master) LP
Private Equity FundFund ID 805-2616755366Cayman Islands
Gross assets
$1.87B
Min. investment
—
Beneficial owners
171
Size rank
Top 4%
Audited
Yes
Structure
Master
About this fund
Biopharma Credit Investments V (master) LP is a private equity fund managed by Pharmakon Advisors, LP. The fund reports $1.9 billion in gross assets, placing it among the top 4% of private funds by size. Its financial statements are audited annually. Private funds are not required to publicly disclose returns; Form ADV reports assets, structure, and service providers, shown above.
Fund details
| Fund ID | 805-2616755366 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | Yes |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
Other funds from this manager
None reported.
Frequently asked questions
How large is Biopharma Credit Investments V (master) LP?
Biopharma Credit Investments V (master) LP reports $1.9 billion in gross assets, among the top 4% of private funds by size.
Who manages Biopharma Credit Investments V (master) LP?
Biopharma Credit Investments V (master) LP is managed by Pharmakon Advisors, LP.
Does Biopharma Credit Investments V (master) LP disclose returns?
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.
Manager
New York, NY
Service providers
Prime broker
None reported
Custodian
Administrator
Auditor
Marketer
Reported gross assets
$1.87B▲ 10%
Mar '25Form ADV, monthlyAug '26
How this fund compares
Gross assetsTop 4%
Larger than 96% of 67,603 private funds
Gross assets vs Private Equity FundsTop 3%
Larger than 97% of 31,272 private equity funds
Investor base
Adviser & related persons1%
Funds of funds13%
Non-U.S. persons22%
Share of the fund's beneficial ownership reported on Form ADV. Categories can overlap.